| Literature DB >> 25506364 |
Nina Brodin1, Peter Lindholm2, Claudia Lennartsson3, Malin Nygren-Bonnier3.
Abstract
In Ankylosing Spondylitis (AS), thoracic range of motion is often greatly limited. The objective of the study was to describe the effects of 12 weeks of Glossopharyngeal Insufflation (GI) training in patients with AS. Dynamic spirometry included vital capacity, forced expiratory volume, and peak expiratory flow. Thoracic and lumbar range of motion was assessed by tragus-to-wall distance, modified Schober test, and tape measure. Disease activity, activity limitation, and health perception were assessed using the BAS-Indices, and tension in the thoracic region during GI was assessed using the Borg CR-10 scale. Adherence to training was recorded in an activity log, along with any remarks on the training. Ten patients were recruited and six male patients fulfilled the study protocol. Three patients were able to learn GI by exceeding their maximal vital capacity with 5% using GI. A significant increase in thoracic range of motion both on costae IV (P = 0.04) and at the level of the xiphoid process (P = 0.04) was seen. Thus, patients with AS can practice GI, it is safe if maximal exertion is avoided, and patients with some mobility in the chest can increase their lung function substantially by performing GI during 12 weeks.Entities:
Year: 2014 PMID: 25506364 PMCID: PMC4258913 DOI: 10.1155/2014/594708
Source DB: PubMed Journal: Int J Rheumatol ISSN: 1687-9260
Baseline characteristics of the 6 subjects fulfilling the study protocol.
| Median (range) | |
|---|---|
| Gender, male/female ( | 6/0 |
| Age, years | 42 (26–55) |
| Disease duration, years | 14 (0.5–28) |
| Smoking, yes/no ( | 0/6 |
| Weight, kg | 92.5 (81–106) |
| Height, cm | 180.5 (177–189) |
| BMI1, kg/m2 | 28.1 (24.9–30.0) |
| VC2 % of predicted | 96 (67–102) |
| PEF3 % of predicted | 102.5 (90–113) |
1Body mass index (BMI), 2vital capacity (VC), and 3peak expiratory flow (PEF).
Individual results from baseline (pre) and follow-up after 12 weeks (post) of Glossopharyngeal Insufflation for the six patients fulfilling the study protocol.
| Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | Case 6 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Pre | Post | Pre | Post | Pre | Post | Pre | Post | |
| VC1, L | 4.84 | 5.18 | 5.63 | 4.94 | 3.68 | 3.95 | 3.11 | 3.14 | 5.79 | 5.69 | 5.56 | 5.89 |
| PEF2, L/min | 557 | 605 | 545 | 539 | 561 | 528 | 589 | 559 | 586 | 491 | 625 | 656 |
| C7-30, cm | 5.0 | 5.5 | 6.0 | 5.5 | 3.5 | 3.5 | 0.5 | 1.0 | 3.0 | — | 2.0 | 4.0 |
| Tragus-wall, cm | 10 | 9.5 | 11.5 | 11.5 | 11.5 | 11.0 | 18 | 17.0 | 10.5 | — | 16 | 13..5 |
| BX3 diff, cm | 7.0 | 8.5 | 6.0 | 7.5 | 2.0 | 4.0 | 4.0 | 5.0 | 6.0 | — | 7.0 | 9.5 |
| BC4 diff, cm | 9.5 | 11.5 | 4.5 | 6.5 | 3.0 | 3.5 | 2.0 | 2.0 | 4.0 | — | 6.0 | 8.0 |
| BAS DAI5, 0–10 | 3.4 | 3.4 | 0.4 | 1.3 | 1.8 | 2.0 | 1.5 | 2.3 | 2.3 | — | 0.7 | 0.8 |
| BASFI6, 0–10 | 0.6 | 0.25 | 0.2 | 0.7 | 1.5 | 2.0 | 1.0 | 1.0 | 1.1 | — | 2.1 | 1.9 |
| BASG17, 0–10 | 1.6 | 2.4 | 0.4 | 2.6 | 2.5 | 2.3 | 0.2 | 0.3 | 1.9 | — | 0.6 | 1.2 |
| VCGI8 (L) | 6.75 | 5.40 | 4.05 | 3.57 | 5.76 | 7.78 | ||||||
| VC increase with GI (%) | 30.3 | 1.4 | 2.5 | 13.7 | 1.2 | 32.1 | ||||||
1Vital capacity (VC), 2peak expiratory flow (PEF), 3level of xiphoid process on the chest wall (BX) difference of inhalation and exhalation, 4level of the fourth costae on the chest wall (BC) difference of inhalation and exhalation, 5the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), 6the Bath Ankylosing Spondylitis Functional Index (BASFI), 7the Bath Ankylosing Spondylitis Global Index (BASG1), and 8vital Capacity using Glossopharyngeal Insufflation (VCGI).
Figure 1Difference in thoracic range of motion between maximal inhalation and exhalation at the level of the xiphoid process before (pre) and after (post) 12 weeks of Glossopharyngeal Insufflation (missing data on 1 subject).
Figure 2Difference in thoracic range of motion between maximal inhalation and exhalation at the level of the fourth costae before (pre) and after (post) 12 weeks of Glossopharyngeal Insufflation (missing data on 1 subject).